Spontaneous pneumothorax during nintedanib therapy in patients with systemic sclerosis‐associated interstitial lung disease

Interstitial lung disease (ILD) is a common complication of systemic sclerosis (SSc). Nintedanib, an antifibrotic drug, has recently been approved for treating SSc‐ILD. Although there have been no reports suggesting the development of pneumothorax with nintedanib use, its safety in patients with imp...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Respirol Case Rep
المؤلفون الرئيسيون: Sumi, Toshiyuki, Uehara, Hirofumi, Tada, Makoto, Keira, Yoshiko, Kamada, Koki, Shijubou, Naoki, Yamada, Yuichi, Nakata, Hisashi, Mori, Yuji, Chiba, Hirofumi
التنسيق: Artigo
اللغة:Inglês
منشور في: John Wiley & Sons, Ltd 2021
الموضوعات:
Case Reports
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7840496/
https://ncbi.nlm.nih.gov/pubmed/33552523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.716
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة